Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Phenobarbital for Agitated Delirium [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating phenobarbital for agitation in delirium is listed as not yet recruiting, sponsored by Duke University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Luminal (phenobarbital)

Snippet

Sponsor: Duke University | Conditions: Agitated Delirium, Delirium Confusional State | Phase 3 | Status: NOT_YET_RECRUITING